FDA has recently published final Guidance for Industry, entitled “Recommended Acceptable Intake Limits for Nitrosamine Drug...

FDA is proposing to amend its drug product labeling rules for Medication Guide and other information templates provided to...

In response to complaints that patients' sensitivity to pain or level of discomfort increased when using immediate-release (IR) and...